Laporan Laba Rugi (TTM)
Laporan Laba Rugi Amplia Therapeutics Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 2 | 3 | 4 | 4 | 3 | 4 | 4 |
| Change (%) | 35.75 | 26.34 | -3.18 | -3.28 | 19.05 | 16.00 | 25.38 | 20.24 | -30.11 | -43.08 | 28.54 | 22.20 | 69.15 | 40.88 | -11.69 | -13.24 | 5.46 | 5.18 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 77.22 | 43.57 | 2.12 | 2.08 | -26.23 | -35.55 | 9.02 | 8.27 | 34.25 | 25.51 | 10.48 | 9.48 | 9.41 | 8.60 | -4.57 | -4.79 | -23.78 | -31.21 | |
| % of Revenue | 13.71 | 17.90 | 20.35 | 21.46 | 22.65 | 14.03 | 7.80 | 6.78 | 6.10 | 11.73 | 25.86 | 22.22 | 19.91 | 12.88 | 9.93 | 10.73 | 11.77 | 8.51 | 5.57 |
| Gross Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 3 | 4 | 4 | 3 | 3 | 4 |
| Change (%) | 29.16 | 22.58 | -4.53 | -4.74 | 32.31 | 24.42 | 26.77 | 21.11 | -34.29 | -52.19 | 34.84 | 25.84 | 84.00 | 45.65 | -12.48 | -14.26 | 9.36 | 8.56 | |
| % of Revenue | 86.29 | 82.10 | 79.65 | 78.54 | 77.35 | 85.97 | 92.20 | 93.22 | 93.90 | 88.27 | 74.14 | 77.78 | 80.09 | 87.12 | 90.07 | 89.27 | 88.23 | 91.49 | 94.43 |
| SG&A | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Change (%) | 7.82 | 7.25 | 3.35 | 3.24 | 8.94 | 8.21 | 9.17 | 8.40 | 9.95 | 9.05 | 3.89 | 3.74 | 1.83 | 1.80 | 1.38 | 1.36 | -0.24 | -0.24 | |
| % of Revenue | 130.49 | 103.64 | 87.98 | 93.91 | 100.24 | 91.73 | 85.56 | 74.50 | 67.16 | 105.65 | 202.40 | 163.58 | 138.87 | 83.60 | 60.41 | 69.36 | 81.04 | 76.65 | 72.70 |
| R&D | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 5 | 5 | 4 | 3 | 5 | 6 | 6 | 6 | 7 | 8 |
| Change (%) | 23.30 | 18.90 | 12.46 | 11.08 | 18.26 | 15.44 | 29.52 | 22.79 | -10.94 | -12.28 | -14.24 | -16.60 | 36.59 | 26.79 | 5.22 | 4.96 | 8.71 | 8.02 | |
| % of Revenue | 168.72 | 153.25 | 144.23 | 167.52 | 192.39 | 191.12 | 190.19 | 196.47 | 200.63 | 255.67 | 394.03 | 262.88 | 179.40 | 144.86 | 130.36 | 155.34 | 187.94 | 193.74 | 198.97 |
| OpEx | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 7 | 8 | 8 | 7 | 7 | 6 | 8 | 9 | 9 | 10 | 10 | 11 |
| Change (%) | 19.21 | 16.11 | 8.47 | 7.81 | 12.11 | 10.80 | 23.04 | 18.73 | -4.53 | -4.75 | -7.15 | -7.70 | 20.42 | 16.96 | 3.55 | 3.43 | 4.72 | 4.51 | |
| % of Revenue | 312.99 | 274.84 | 252.60 | 282.98 | 315.42 | 297.03 | 283.72 | 278.43 | 274.92 | 375.53 | 628.45 | 453.94 | 342.84 | 244.08 | 202.64 | 237.62 | 283.29 | 281.30 | 279.51 |
| Operating Income | -2 | -2 | -2 | -3 | -3 | -3 | -4 | -4 | -5 | -6 | -6 | -5 | -5 | -5 | -5 | -5 | -6 | -7 | -7 |
| Change (%) | 11.44 | 10.26 | 16.10 | 13.87 | 8.89 | 8.16 | 21.77 | 17.88 | 10.09 | 9.17 | -13.91 | -16.15 | 0.36 | 0.36 | 18.41 | 15.55 | 4.31 | 4.14 | |
| % of Revenue | -212.99 | -174.84 | -152.60 | -182.98 | -215.42 | -197.03 | -183.72 | -178.43 | -174.92 | -275.53 | -528.45 | -353.94 | -242.84 | -144.08 | -102.64 | -137.62 | -183.29 | -181.30 | -179.51 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
| Change (%) | 100.00 | 701.91 | 87.52 | 105.69 | 51.39 | 28.31 | 22.06 | -3.47 | -3.60 | 5.48 | 5.19 | -17.91 | -21.82 | ||||||
| % of Revenue | -0.03 | -0.06 | -0.37 | -0.58 | -1.70 | -4.53 | -4.52 | -4.51 | -2.58 | -1.76 | -2.11 | -2.55 | -1.99 | -1.48 | |||||
| Net Income | -2 | -2 | -2 | -3 | -3 | -3 | -4 | -4 | -5 | -6 | -6 | -5 | -4 | -4 | -5 | -5 | -6 | -6 | -7 |
| Change (%) | 11.81 | 10.56 | 17.79 | 15.10 | 8.92 | 8.19 | 21.80 | 17.90 | 9.64 | 8.79 | -14.28 | -16.66 | 0.49 | 0.49 | 18.71 | 15.76 | 3.10 | 3.01 | |
| % of Revenue | -206.39 | -169.98 | -148.75 | -180.96 | -215.34 | -197.01 | -183.74 | -178.50 | -175.02 | -274.56 | -524.80 | -349.98 | -238.69 | -141.80 | -101.14 | -135.96 | -181.41 | -177.35 | -173.69 |
Source: Capital IQ
